Carrick Therapeutics
Founded 2015 · 5 known investors
Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization. The company focuses on developing and advancing cancer treatments through clinical development and business development activities.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
TP
Timothy PearsonCEO
AB
Ash BahlCSO
JH
Jenny HorsfieldCBO
SM
Stuart McIntoshCMO
DS
David SutherlandVP Finance & Controller
Investors · 5
Competitors · 2
by search overlapSolu13 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Bioworld12 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Carrick Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Carrick Therapeutics do?
- Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization. The company focuses on developing and advancing cancer treatments through clinical development and business development activities.
- Who are Carrick Therapeutics's investors?
- Carrick Therapeutics's investors include ARCH Venture Partners, B Capital Group, B4 Capital, Cambridge Innovation Capital, Lightstone Ventures.